Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'NUCLEAR PROTEIN-2' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 76 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Lin, J; Johannsen, E; Robertson, E; Kieff, E
      Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2

      JOURNAL OF VIROLOGY
    2. Hassan, AH; Neely, KE; Vignali, M; Reese, JC; Workman, JL
      Promoter targeting of chromatin-modifying complexes

      FRONTIERS IN BIOSCIENCE
    3. Izumi, KM
      Identification of EBV transforming genes by recombinant EBV technology

      SEMINARS IN CANCER BIOLOGY
    4. Zimber-Strobl, U; Strobl, LJ
      EBNA2 and Notch signalling in Epstein-Barr virus mediated immortalization of B lymphocytes

      SEMINARS IN CANCER BIOLOGY
    5. Bornkamm, GW; Hammerschmidt, W
      Molecular virology of Epstein-Barr virus

      PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES
    6. Blaschke, S; Hannig, H; Buske, C; Kaup, FJ; Hunsmann, G; Bodemer, W
      Expression of the simian Epstein-Barr virus-encoded latent membrane protein-1 in malignant lymphomas of SIV-infected rhesus macaques

      JOURNAL OF MEDICAL VIROLOGY
    7. Damania, B; Jung, JU
      Comparative analysis of the transforming mechanisms of Epstein-Barr virus,Kaposi's sarcoma-associated herpesvirus, and Herpesvirus Saimiri

      ADVANCES IN CANCER RESEARCH, VOL 80
    8. Tao, JG; Wasik, MA
      Epstein-Barr virus associated polymorphic lymphoproliferative disorders occurring in nontransplant settings

      LABORATORY INVESTIGATION
    9. Spender, LC; Cornish, GH; Rowland, B; Kempkes, B; Farrell, PJ
      Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection

      JOURNAL OF VIROLOGY
    10. Harada, S; Yalamanchili, R; Kieff, E
      Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association

      JOURNAL OF VIROLOGY
    11. Groves, AK; Cotter, MA; Subramanian, C; Robertson, ES
      The latency-associated nuclear antigen encoded by kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters

      JOURNAL OF VIROLOGY
    12. McCann, EM; Kelly, GL; Rickinson, AB; Bell, AI
      Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP asa co-activator of EBNA2 function

      JOURNAL OF GENERAL VIROLOGY
    13. Kenney, JL; Guinness, ME; Reiss, M; Lacy, J
      Antisense to the Epstein-Barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) sensitizes EBV-immortalized B cells to transforming growth factor-beta and chemotherapeutic agents

      INTERNATIONAL JOURNAL OF CANCER
    14. Noguchi, T; Ikeda, K; Yamamoto, K; Yoshida, I; Ashiba, A; Tsuchiyama, J; Shinagawa, K; Yoshino, T; Takata, M; Harada, M
      Antisense oligodeoxynucleotides to latent membrane protein 1 induce growthinhibition, apoptosis and Bcl-2 suppression in Epstein-Barr virus (EBV)-transformed B-lymphoblastoid cells, but not in EBV-positive natural killer cell lymphoma cells

      BRITISH JOURNAL OF HAEMATOLOGY
    15. Delecluse, HJ; Hammerschmidt, W
      The genetic approach to the Epstein-Barr virus: from basic virology to gene therapy

      JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY
    16. Liu, JH; He, LS; Collins, I; Ge, H; Libutti, D; Li, JF; Egly, JM; Levens, D
      The FBP interacting repressor targets TFIIH to inhibit activated transcription

      MOLECULAR CELL
    17. Wang, L; Grossman, SR; Kieff, E
      Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    18. Zhou, SF; Fujimuro, M; Hsieh, JJD; Chen, L; Hayward, SD
      A role for SKIP in EBNA2 activation of CBF1-repressed promoters

      JOURNAL OF VIROLOGY
    19. Cotter, M; Callahan, J; Aster, J; Robertson, E
      Intracellular forms of human NOTCH1 functionally activate essential Epstein-Barr virus major latent promoters in the Burkitt's lymphoma BJAB cell line but repress these promoters in Jurkat cells

      JOURNAL OF VIROLOGY
    20. Zhao, B; Sample, CE
      Epstein-Barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an Spi-1/Spi-B binding site

      JOURNAL OF VIROLOGY
    21. Lin, CS; Kuo, HH; Chen, JY; Yang, CS; Wang, WB
      Epstein-Barr virus nuclear antigen 2 retards cell growth, induces p21(WAF1) expression, and modulates p53 activity post-translationally

      JOURNAL OF MOLECULAR BIOLOGY
    22. Guinness, ME; Kenney, JL; Reiss, M; Lacy, J
      Bcl-2 antisense oligodeoxynucleotide therapy of Epstein-Barr virus-associated lymphoproliferative disease in severe combined immunodeficient mice

      CANCER RESEARCH
    23. Gires, O; Kohlhuber, F; Kilger, E; Baumann, M; Kieser, A; Kaiser, C; Zeidler, R; Scheffer, B; Ueffing, M; Hammerschmidt, W
      Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

      EMBO JOURNAL
    24. Cohen, JI; Lekstrom, K
      Epstein-Barr virus BARF1 protein is dispensable for B-cell transformation and inhibits alpha interferon secretion from mononuclear cells

      JOURNAL OF VIROLOGY
    25. Kaiser, C; Laux, G; Eick, D; Jochner, N; Bornkamm, GW; Kempkes, B
      The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2

      JOURNAL OF VIROLOGY
    26. Cho, YG; Gordadze, AV; Ling, PD; Wang, F
      Evolution of two types of rhesus lymphocryptovirus similar to type 1 and type 2 Epstein-Barr virus

      JOURNAL OF VIROLOGY
    27. Dolcetti, R; Quaia, M; Gloghini, A; De Re, V; Zancai, P; Cariati, R; Babuin, L; Cilia, AM; Rizzo, S; Carbone, A; Boiocchi, M
      Biologically relevant phenotypic changes and enhanced growth properties induced in B lymphocytes by an EBV strain derived from a histologically aggressive Hodgkin's disease

      INTERNATIONAL JOURNAL OF CANCER
    28. DOLCETTI R; ZANCAI P; CARIATI R; BOIOCCHI M
      IN-VITRO EFFECTS OF RETINOIDS ON THE PROLIFERATION AND DIFFERENTIATION FEATURES OF EPSTEIN-BARR VIRUS-IMMORTALIZED B-LYMPHOCYTES

      Leukemia & lymphoma
    29. YOKOMORI K; VERRIJZER CP; TJIAN R
      AN INTERPLAY BETWEEN TATA BOX-BINDING PROTEIN AND TRANSCRIPTION FACTORS IIE AND IIA MODULATES DNA-BINDING AND TRANSCRIPTION

      Proceedings of the National Academy of Sciences of the United Statesof America
    30. SJOBLOM A; YANG WW; PALMQVIST L; JANSSON A; RYMO L
      AN ATF CRE ELEMENT MEDIATES BOTH EBNA2-DEPENDENT AND EBNA2-INDEPENDENT ACTIVATION OF THE EPSTEIN-BARR-VIRUS LMP1 GENE PROMOTER/

      Journal of virology
    31. FUENTESPANANA EM; LING PD
      CHARACTERIZATION OF THE CBF2 BINDING-SITE WITHIN THE EPSTEIN-BARR-VIRUS LATENCY-C PROMOTER AND ITS ROLE IN MODULATING EBNA2-MEDIATED TRANSACTIVATION

      Journal of virology
    32. KENNEY JL; GUINNESS ME; CURIEL F; LACY J
      ANTISENSE TO THE EPSTEIN-BARR-VIRUS (EBV)-ENCODED LATENT MEMBRANE-PROTEIN-1 (LMP-1) SUPPRESSES LMP-1 AND BCL-2 EXPRESSION AND PROMOTES APOPTOSIS IN EBV-IMMORTALIZED B-CELLS

      Blood
    33. FLOETTMANN JE; ROWE M
      EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-1 (LMP1) C-TERMINUS ACTIVATION REGION-2 (CTAR2) MAPS TO THE FAR C-TERMINUS AND REQUIRES OLIGOMERIZATION FOR NF-KAPPA-B ACTIVATION

      Oncogene
    34. MILLER WE; MOSIALOS G; KIEFF E; RAABTRAUB N
      EPSTEIN-BARR-VIRUS LMP1 INDUCTION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR IS MEDIATED THROUGH A TRAF SIGNALING PATHWAY DISTINCT FROM NF-KAPPA-B ACTIVATION

      Journal of virology
    35. SCHUBACH WH; HORVATH G; LEVEA C; TIERNEY J
      CHROMATIN STRUCTURE OF THE LYMPHOCYTE FC EPSILON-RECEPTOR GENE (CD23)- IDENTIFICATION OF AN UPSTREAM TRANSCRIPTIONAL ENHANCER

      The Journal of immunology
    36. OHKUMA Y
      MULTIPLE FUNCTIONS OF GENERAL TRANSCRIPTION FACTORS TFIIE AND TFIIH IN TRANSCRIPTION - POSSIBLE POINTS OF REGULATION BY TRANS-ACTING FACTORS

      Journal of Biochemistry
    37. NIEDOBITEK G; AGATHANGGELOU A; NICHOLLS JM
      EPSTEIN-BARR-VIRUS INFECTION AND THE PATHOGENESIS OF NASOPHARYNGEAL CARCINOMA - VIRAL GENE-EXPRESSION, TUMOR-CELL PHENOTYPE, AND THE ROLE OF THE LYMPHOID STROMA

      Seminars in cancer biology
    38. FLOETTMANN JE; WARD K; RICKINSON AB; ROWE M
      CYTOSTATIC EFFECT OF EPSTEIN-BARR-VIRUS LATENT MEMBRANE PROTEIN-1 ANALYZED USING TETRACYCLINE-REGULATED EXPRESSION IN B-CELL LINES

      Virology
    39. ROBERTSON ES; OOKA T; KIEFF ED
      EPSTEIN-BARR-VIRUS VECTORS FOR GENE DELIVERY TO B-LYMPHOCYTES

      Proceedings of the National Academy of Sciences of the United Statesof America
    40. WU DY; KALPANA GV; GOFF SP; SCHUBACH WH
      EPSTEIN-BARR-VIRUS NUCLEAR-PROTEIN-2 (EBNA2) BINDS TO A COMPONENT OF THE HUMAN SNF-SWI COMPLEX, HSNF5 INI1/

      Journal of virology
    41. JOHANNSEN E; MILLER CL; GROSSMAN SR; KIEFF E
      EBNA-2 AND EBNA-3C EXTENSIVELY AND MUTUALLY EXCLUSIVELY ASSOCIATE WITH RBPJ-KAPPA IN EPSTEIN-BARR VIRUS-TRANSFORMED B-LYMPHOCYTES

      Journal of virology
    42. ROBERTS ML; LUXEMBOURG AT; COOPER NR
      EPSTEIN-BARR-VIRUS BINDING TO CD21, THE VIRUS RECEPTOR, ACTIVATES RESTING B-CELLS VIA AN INTRACELLULAR PATHWAY THAT IS LINKED TO B-CELL INFECTION

      Journal of General Virology
    43. POMPONI F; CARIATI R; ZANCAI P; DEPAOLI P; RIZZO S; TEDESCHI RM; PIVETTA B; DEVITA S; BOIOCCHI M; DOLCETTI R
      RETINOIDS IRREVERSIBLY INHIBIT IN-VITRO GROWTH OF EPSTEIN-BARR VIRUS-IMMORTALIZED B-LYMPHOCYTES

      Blood
    44. SCHUSTER V; OTT G; SEIDENSPINNER S; KRETH HW
      COMMON EPSTEIN-BARR-VIRUS (EBV) TYPE-1 VARIANT STRAINS IN BOTH MALIGNANT AND BENIGN EBV-ASSOCIATED DISORDERS

      Blood
    45. YAO GQ; TSAI CH; CHENG YC
      CHARACTERIZATION OF SUBLINES OF EPSTEIN-BARR-VIRUS PRODUCING HR-1 CELLS AND ITS IMPLICATION IN VIRUS PROPAGATION IN CULTURE

      Virus genes
    46. CRAWFORD DH; THOMAS JA; GREGORY CD; CATOVSKY D; CHAGGAR K
      INDUCTION OF LATENT MEMBRANE-PROTEIN EXPRESSION IN IN-VITRO EPSTEIN-BARR VIRUS-INFECTED LEUKEMIC B-LYMPHOCYTES BY INTERLEUKIN-4 AND ANTIBODIES TO CD40

      Leukemia
    47. MOSIALOS G; BIRKENBACH M; YALAMANCHILI R; VANARSDALE T; WARE C; KIEFF E
      THE EPSTEIN-BARR-VIRUS TRANSFORMING PROTEIN LMP1 ENGAGES SIGNALING PROTEINS FOR THE TUMOR-NECROSIS-FACTOR RECEPTOR FAMILY

      Cell
    48. KEMPKES B; PICH D; ZEIDLER R; HAMMERSCHMIDT W
      IMMORTALIZATION OF HUMAN PRIMARY B-LYMPHOCYTES IN-VITRO WITH DNA

      Proceedings of the National Academy of Sciences of the United Statesof America
    49. MILLER WE; EARP HS; RAABTRAUB N
      THE EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN-1 INDUCES EXPRESSION OF THE EPIDERMAL GROWTH-FACTOR RECEPTOR

      Journal of virology
    50. KAYE KM; IZUMI KM; MOSIALOS G; KIEFF E
      THE EPSTEIN-BARR-VIRUS LMP1 CYTOPLASMIC CARBOXY-TERMINUS IS ESSENTIALFOR B-LYMPHOCYTE TRANSFORMATION - FIBROBLAST COCULTIVATION COMPLEMENTS A CRITICAL FUNCTION WITHIN THE TERMINAL-155 RESIDUES

      Journal of virology
    51. KLAMAN LD; THORLEYLAWSON DA
      CHARACTERIZATION OF THE CD48 GENE DEMONSTRATES A POSITIVE ELEMENT THAT IS SPECIFIC TO EPSTEIN-BARR VIRUS-IMMORTALIZED B-CELL LINES AND CONTAINS AN ESSENTIAL NF-KAPPA-B SITE

      Journal of virology
    52. ROBERTSON E; KIEFF E
      REDUCING THE COMPLEXITY OF THE TRANSFORMING EPSTEIN-BARR-VIRUS GENOMETO 64 KILOBASE PAIRS

      Journal of virology
    53. ROCHFORD R; MOSIER DE
      DIFFERENTIAL EPSTEIN-BARR-VIRUS GENE-EXPRESSION IN B-CELL SUBSETS RECOVERED FROM LYMPHOMAS IN SCID MICE AFTER TRANSPLANTATION OF HUMAN PERIPHERAL-BLOOD LYMPHOCYTES

      Journal of virology
    54. WALTER J; SCHIRRMACHER V; MOSIER D
      INDUCTION OF CD44 EXPRESSION BY THE EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN LMP1 IS ASSOCIATED WITH LYMPHOMA DISSEMINATION

      International journal of cancer
    55. SHIMAKAGE M; KURATA A; INOUE H; OKAMOTO Y; YUTSUDO M; HAKURA A
      TUMORIGENICITY OF EBNA2-TRANSFECTED CELLS

      FEBS letters
    56. HOLLYOAKE M; STUHLER A; FARRELL P; GORDON J; SINCLAIR A
      THE NORMAL-CELL CYCLE ACTIVATION PROGRAM IS EXPLOITED DURING THE INFECTION OF QUIESCENT B-LYMPHOCYTES BY EPSTEIN-BARR-VIRUS

      Cancer research
    57. SUZUSHIMA H; ASOU N; FUJIMOTO T; NISHIMURA S; OKUBO T; YAMASAKI H; OSATO M; MATSUOKA M; TSUKAMOTO A; TAKAI K; KAWANO F; TAKATSUKI K
      LACK OF THE EXPRESSION OF EBNA-2 AND LMP-1 IN T-CELL NEOPLASMS POSSESSING EPSTEIN-BARR-VIRUS

      Blood
    58. PATHMANATHAN R; PRASAD U; CHANDRIKA G; SADLER R; FLYNN K; RAABTRAUB N
      UNDIFFERENTIATED, NONKERATINIZING, AND SQUAMOUS-CELL CARCINOMA OF THENASOPHARYNX - VARIANTS OF EPSTEIN-BARR VIRUS-INFECTED NEOPLASIA

      The American journal of pathology
    59. MIYAZAKI I; CHEUNG RK; DOSCH HM
      THE ROLE OF VIL-10 AND OTHER EBV LATENCY GENES EARLY DURING B-CELL GROWTH TRANSFORMATION

      Seminars in virology
    60. PINKUS GS; LONES M; SHINTAKU IP; SAID JW
      IMMUNOHISTOCHEMICAL DETECTION OF EPSTEIN-BARR VIRUS-ENCODED LATENT MEMBRANE-PROTEIN IN REED-STERNBERG CELLS AND VARIANTS OF HODGKINS-DISEASE

      Modern pathology
    61. ROCHFORD R; MOSIER DE
      IMMUNOBIOLOGY OF EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOMAS

      Clinical immunology and immunopathology
    62. REA D; FOURCADE C; LEBLOND V; ROWE M; JOAB I; EDELMAN L; BITKER MO; GANDJBAKHCH I; SUBERBIELLE C; FARCET JP; RAPHAEL M
      PATTERNS OF EPSTEIN-BARR-VIRUS LATENT AND REPLICATIVE GENE-EXPRESSIONIN EPSTEIN-BARR-VIRUS B-CELL LYMPHOPROLIFERATIVE DISORDERS AFTER ORGAN-TRANSPLANTATION

      Transplantation
    63. ROWE M; PENGPILON M; HUEN DS; HARDY R; CROOMCARTER D; LUNDGREN E; RICKINSON AB
      UP-REGULATION OF BCL-2 BY THE EPSTEIN-BARR-VIRUS LATENT MEMBRANE-PROTEIN LMP1 - A B-CELL-SPECIFIC RESPONSE THAT IS DELAYED RELATIVE TO NF-KAPPA-B ACTIVATION AND TO INDUCTION OF CELL-SURFACE MARKERS

      Journal of virology
    64. IZUMI KM; KAYE KM; KIEFF ED
      EPSTEIN-BARR-VIRUS RECOMBINANT MOLECULAR-GENETIC ANALYSIS OF THE LMP1AMINO-TERMINAL CYTOPLASMIC DOMAIN REVEALS A PROBABLE STRUCTURAL ROLE,WITH NO COMPONENT ESSENTIAL FOR PRIMARY B-LYMPHOCYTE GROWTH TRANSFORMATION

      Journal of virology
    65. ROBERTSON ES; TOMKINSON B; KIEFF E
      AN EPSTEIN-BARR-VIRUS WITH A 58-KILOBASE-PAIR DELETION THAT INCLUDES BARF0 TRANSFORMS B-LYMPHOCYTES IN-VITRO

      Journal of virology
    66. WALLING DM; PERKINS AG; WEBSTERCYRIAQUE J; RESNICK L; RAABTRAUB N
      THE EPSTEIN-BARR-VIRUS EBNA-2 GENE IN ORAL HAIRY LEUKOPLAKIA - STRAINVARIATION, GENETIC-RECOMBINATION, AND TRANSCRIPTIONAL EXPRESSION

      Journal of virology
    67. TAYLOR KA; WETZEL S; LYLES DS; POLLOK BA
      DUAL EBNA1 PROMOTER USAGE BY EPSTEIN-BARR-VIRUS IN HUMAN B-CELL LINESEXPRESSING UNIQUE INTERMEDIATE CELLULAR PHENOTYPES

      Journal of virology
    68. SAMPLE J; KIEFF EF; KIEFF ED
      EPSTEIN-BARR-VIRUS TYPE-1 AND TYPE-2 HAVE NEARLY IDENTICAL LMP-1 TRANSFORMING GENES

      Journal of General Virology
    69. WEI MX; MOULIN JC; DECAUSSIN G; BERGER F; OOKA T
      EXPRESSION AND TUMORIGENICITY OF THE EPSTEIN-BARR-VIRUS BARF1 GENE INHUMAN LOUCKES B-LYMPHOCYTE CELL-LINE

      Cancer research
    70. HARUNA Y; HAYASHI N; KAMADA T; HYTIROGLOU P; THUNG SN; GERBER MA
      EXPRESSION OF HEPATITIS-C VIRUS IN HEPATOCELLULAR-CARCINOMA

      Cancer
    71. DOYLE MG; CATOVSKY D; CRAWFORD DH
      INFECTION OF LEUKEMIC B-LYMPHOCYTES BY EPSTEIN-BARR-VIRUS

      Leukemia
    72. SHARP TV; SCHWEMMLE M; JEFFREY I; LAING K; MELLOR H; PROUD CG; HILSE K; CLEMENS MJ
      COMPARATIVE-ANALYSIS OF THE REGULATION OF THE INTERFERON-INDUCIBLE PROTEIN-KINASE PKR BY EPSTEIN-BARR-VIRUS RNAS EBER-1 AND EBER-2 AND ADENOVIRUS VA(I) RNA

      Nucleic acids research
    73. LING PD; RAWLINS DR; HAYWARD SD
      THE EPSTEIN-BARR-VIRUS IMMORTALIZING PROTEIN EBNA-2 IS TARGETED TO DNA BY A CELLULAR ENHANCER-BINDING PROTEIN

      Proceedings of the National Academy of Sciences of the United Statesof America
    74. TOMKINSON B; ROBERTSON E; YALAMANCHILI R; LONGNECKER R; KIEFF E
      EPSTEIN-BARR-VIRUS RECOMBINANTS FROM OVERLAPPING COSMID FRAGMENTS

      Journal of virology
    75. HAMILTONDUTOIT SJ; REA D; RAPHAEL M; SANDVEJ K; DELECLUSE HJ; GISSELBRECHT C; MARELLE L; VANKRIEKEN JHJM; PALLESEN G
      EPSTEIN-BARR VIRUS-LATENT GENE-EXPRESSION AND TUMOR-CELL PHENOTYPE INACQUIRED IMMUNODEFICIENCY SYNDROME-RELATED NON-HODGKINS-LYMPHOMA - CORRELATION OF LYMPHOMA PHENOTYPE WITH 3 DISTINCT PATTERNS OF VIRAL LATENCY

      The American journal of pathology
    76. PICCHIO GR; COHEN JI; WYATT ER; MOSIER DE
      ENHANCED TUMORIGENICITY OF AN EPSTEIN-BARR VIRUS-TRANSFORMED LYMPHOBLASTOID CELL-LINE IS ASSOCIATED WITH A UNIQUE 1-18 CHROMOSOMAL TRANSLOCATION AND DECREASED EXPRESSION OF LYMPHOCYTE FUNCTION-ASSOCIATED ANTIGEN-1A (CD11A)

      The American journal of pathology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/08/20 alle ore 17:00:20